BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 235 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $380 | +5.6% | 53,640 | +4.9% | 0.00% | +50.0% |
| Q2 2023 | $360 | -24.8% | 51,121 | -11.0% | 0.00% | -33.3% |
| Q1 2023 | $479 | -25.6% | 57,430 | +2.4% | 0.00% | -40.0% |
| Q4 2022 | $644 | -99.9% | 56,078 | -8.1% | 0.01% | -16.7% |
| Q3 2022 | $769,000 | +153.0% | 61,051 | +112.4% | 0.01% | +200.0% |
| Q2 2022 | $304,000 | -48.6% | 28,741 | -20.9% | 0.00% | -33.3% |
| Q1 2022 | $591,000 | +24.9% | 36,342 | +6.4% | 0.00% | +50.0% |
| Q4 2021 | $473,000 | +19.1% | 34,141 | +23.6% | 0.00% | 0.0% |
| Q3 2021 | $397,000 | +9.7% | 27,631 | +20.5% | 0.00% | 0.0% |
| Q2 2021 | $362,000 | +82.8% | 22,923 | +17.8% | 0.00% | +100.0% |
| Q1 2021 | $198,000 | +67.8% | 19,465 | +23.1% | 0.00% | 0.0% |
| Q4 2020 | $118,000 | +45.7% | 15,813 | +12.5% | 0.00% | 0.0% |
| Q2 2018 | $81,000 | -22.1% | 14,060 | -35.4% | 0.00% | 0.0% |
| Q1 2018 | $104,000 | -32.9% | 21,773 | -31.1% | 0.00% | 0.0% |
| Q4 2017 | $155,000 | +573.9% | 31,595 | +284.2% | 0.00% | – |
| Q2 2016 | $23,000 | +4.5% | 8,224 | +8.1% | 0.00% | – |
| Q1 2016 | $22,000 | -60.0% | 7,609 | +42.5% | 0.00% | – |
| Q4 2015 | $55,000 | -32.1% | 5,341 | -24.8% | 0.00% | -100.0% |
| Q3 2015 | $81,000 | +145.5% | 7,106 | +217.5% | 0.00% | – |
| Q2 2015 | $33,000 | +106.2% | 2,238 | +28.5% | 0.00% | – |
| Q1 2015 | $16,000 | -23.8% | 1,742 | +0.2% | 0.00% | – |
| Q4 2014 | $21,000 | +5.0% | 1,739 | -14.0% | 0.00% | – |
| Q3 2014 | $20,000 | -4.8% | 2,022 | +22.0% | 0.00% | – |
| Q2 2014 | $21,000 | +16.7% | 1,657 | 0.0% | 0.00% | – |
| Q1 2014 | $18,000 | +50.0% | 1,657 | +1.5% | 0.00% | – |
| Q4 2013 | $12,000 | – | 1,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 3,846,154 | $27,230,770 | 26.28% |
| Prosight Management, LP | 2,408,135 | $17,049,596 | 5.40% |
| Kynam Capital Management, LP | 3,133,193 | $22,183,006 | 3.63% |
| Saturn V Capital Management LP | 982,458 | $6,955,803 | 2.91% |
| AlphaCentric Advisors LLC | 649,000 | $4,594,920 | 2.61% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $12,744,000 | 1.80% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 791,671 | $5,605,031 | 1.70% |
| Eversept Partners, LP | 2,479,103 | $17,552,049 | 1.48% |
| DAFNA Capital Management LLC | 652,000 | $4,616,160 | 1.44% |
| Avoro Capital Advisors LLC | 11,550,000 | $81,774,000 | 1.28% |